FDA News

FDA Advisers Urge Approval of Cangene’s Botulism-Fighting Biologic Citing scarce treatment options for botulism, the FDA’s Blood Products Advisory Committee has recommended approval of Cangene’s botulinum antitoxin derived from equine sources. Efficacy studies of the Canadian company’s Botulism Antitoxin Heptavalent… » Read More